EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GelMA Hydrogel as a Promising Delivery System for Osthole in the Treatment of Rheumatoid Arthritis: Targeting the miR-1224-3p/AGO1 Axis

Weilin Zhang iD, Zhencong Li iD, Zhiwen Dai, Siyuan Chen, Weixiong Guo, Zhongwei Wang, Jinsong Wei

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241713210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Weilin Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spinal Degeneration and Deformity Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Autoimmune Diseases, MicroRNAs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is a multifaceted, chronic, progressive autoimmune disease. This study aims to explore the potential benefits of an enhanced drug delivery system utilizing optimized Gelatin Methacryloyl (GelMA) vectors in RA management. We evaluated the levels of miR-1124-3p and AGO1 in RA tissues and cell lines using qPCR, WB, and immunofluorescence. The effects of osthole on inflammatory response and joint morphology were determined by qPCR, H&E staining, and micro-CT. The data showed that miR-1224-3p was downregulated in RA tissues and HUM-iCell-s010RA cells, while the overexpression of miR-1224-3p in HUM-iCell-s010RA cells reduced the expression of IL-6 and IL-1β. Luciferase assay demonstrated that AGO1 was a direct target gene of miR-1224-3p. Additionally, osthole treatment increased miR-1224-3p levels and decreased AGO1 expression. The release data showed that osthole loaded on GelMA was released at a slower rate than free osthole. Further studies in a mouse model of CIA confirmed that osthole-loaded GelMA was more effective in attenuating osteopenia in RA as well as alleviating autoimmune arthritis. These findings suggest that osthole can regulate the miR-1224-3p/AGO1 axis in RASFs cells and has the potential to be developed as a clinical anti-RA drug. GelMA could provide a new approach to long-term RA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAutoimmune DiseasesMicroRNAsAnimalsMiceHydrogelsGelatinMethacrylatesCoumarinsEukaryotic Initiation FactorsArgonaute Proteins

Stichwörter der Autor:innen

AGO1GelMAostholerheumatoid arthritis

Substanzen

HydrogelsMicroRNAsgelatin methacryloylGelatinMethacrylatesostholCoumarinsMIRN1224 microRNA, humanAGO1 protein, humanEukaryotic Initiation Factors

Autor:innen und Institutionen

  • Department of Spinal Degeneration and Deformity Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China.

ORCID-Profile: Weilin Zhang, Zhencong Li

Förderung

  • Guangdong Natural Science Foundation

Zitieren

APA

Zhang, W., Li, Z., Dai, Z., Chen, S., Guo, W., Wang, Z., & Wei, J. (2023). GelMA Hydrogel as a Promising Delivery System for Osthole in the Treatment of Rheumatoid Arthritis: Targeting the miR-1224-3p/AGO1 Axis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241713210

Vancouver

Zhang W, Li Z, Dai Z, Chen S, Guo W, Wang Z, et al. GelMA Hydrogel as a Promising Delivery System for Osthole in the Treatment of Rheumatoid Arthritis: Targeting the miR-1224-3p/AGO1 Axis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241713210

BibTeX
@article{Zhang2023,
  author = {Zhang, Weilin and Li, Zhencong and Dai, Zhiwen and Chen, Siyuan and Guo, Weixiong and Wang, Zhongwei and Wei, Jinsong},
  title = {GelMA Hydrogel as a Promising Delivery System for Osthole in the Treatment of Rheumatoid Arthritis: Targeting the miR-1224-3p/AGO1 Axis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241713210}
}
Kostenlos starten →